litlas
ログインアカウント作成

Phillip K. Darcy

1993–2025 年に発表

102
論文数
20,004
被引用数
78
h 指数
100
i10 指数

被引用数

Phillip K. Darcy の年別被引用数1994 年: 被引用 3 件1995 年: 被引用 4 件1996 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 15 件2003 年: 被引用 24 件2004 年: 被引用 33 件2005 年: 被引用 50 件2006 年: 被引用 46 件2007 年: 被引用 45 件2008 年: 被引用 43 件2009 年: 被引用 55 件2010 年: 被引用 52 件2011 年: 被引用 35 件2012 年: 被引用 69 件2013 年: 被引用 117 件2014 年: 被引用 123 件2015 年: 被引用 191 件2016 年: 被引用 237 件2017 年: 被引用 302 件2018 年: 被引用 383 件2019 年: 被引用 983 件2020 年: 被引用 1,296 件2021 年: 被引用 1,453 件2022 年: 被引用 1,162 件2023 年: 被引用 916 件2024 年: 被引用 1,233 件2025 年: 被引用 774 件2026 年: 被引用 21 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,999 件、この内訳の 25.2%中国: 引用元論文 2,361 件、この内訳の 19.8%オーストラリア: 引用元論文 567 件、この内訳の 4.8%ドイツ: 引用元論文 556 件、この内訳の 4.7%イギリス: 引用元論文 537 件、この内訳の 4.5%イタリア: 引用元論文 486 件、この内訳の 4.1%フランス: 引用元論文 388 件、この内訳の 3.3%カナダ: 引用元論文 318 件、この内訳の 2.7%スペイン: 引用元論文 266 件、この内訳の 2.2%日本: 引用元論文 255 件、この内訳の 2.1%オランダ: 引用元論文 233 件、この内訳の 2%韓国: 引用元論文 208 件、この内訳の 1.7%
0%25.2%その他 22.9%

機関

分野

  • Medicine54.2%
  • Biochemistry, Genetics and Molecular Biology21.7%
  • Immunology and Microbiology19.6%
  • Engineering2.1%
  • Neuroscience0.7%
  • Computer Science0.5%
  • その他1.2%

トピック

  • Cancer Immunotherapy and Biomarkers11.2%
  • CAR-T cell therapy research11%
  • Immune Cell Function and Interaction8.8%
  • Immunotherapy and Immune Responses7.9%
  • Immune cells in cancer3.9%
  • T-cell and B-cell Immunology2.8%
  • その他54.4%

共著者

全論文

検索で開く
  1. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

    著者: Imran G. House, Peter Savas, Junyun Lai, Amanda X. Y. Chen, Amanda J. Oliver, Zhi L. Teo, Kirsten L. Todd, Melissa A. Henderson, Lauren Giuffrida, Emma V. Petley, Kevin Sek, Sherly Mardiana, Tuba N. Gide, Camelia Quek, Richard A. Scolyer, Georgina V. Long, James S. Wilmott, Sherene Loi, Phillip K. Darcy, Paul A. Beavis - Clinical Cancer Research 2019 被引用: 766

  2. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

    著者: Peter Savas, Balaji Virassamy, Chengzhong Ye, Agus Salim, Christopher Mintoff, Franco Caramia, Roberto Salgado, David J. Byrne, Zhi L. Teo, Sathana Dushyanthen, Ann Byrne, Lironne Wein, Stephen J. Luen, Catherine Poliness, Sophie Nightingale, Anita Skandarajah, David Gyorki, Chantel M. Thornton, Paul A. Beavis, Stephen B. Fox, Phillip K. Darcy, Terence P. Speed, Laura K. Mackay, Paul J. Neeson, Sherene Loi - Nature Medicine 2018 被引用: 991

  3. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

    著者: Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan, James C. Williamson, Katherine Woods, Paul A. Beavis, Enid Y.N. Lam, Melissa A. Henderson, Charles C. Bell, Sabine Stolzenburg, Omer Gilan, Stuart Bloor, Tahereh Noori, David W. Morgens, Michael C. Bassik, Paul J. Neeson, Andreas Behren, Phillip K. Darcy, Sarah‐Jane Dawson, Ilia Voskoboinik, Joseph A. Trapani, Jonathan Cebon, Paul J. Lehner, Mark A. Dawson - Nature 2017 被引用: 969

  4. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

    著者: Jack D. Chan, C. Scheffler, Isabelle Munoz, Kevin Sek, Joel N. Lee, Yukuan Huang, Kah Min Yap, Nicole Y. L. Saw, Jasmine Li, Amanda X. Y. Chen, Cheok Weng Chan, Emily B. Derrick, Kirsten L. Todd, Junming Tong, Phoebe Dunbar, Jiawen Li, Thang X. Hoang, Maria N. de Menezes, Emma V. Petley, Joelle S. Kim, Dat Quoc Nguyen, P. Leung, Joan So, Christian Deo T. Deguit, Joe Jiang Zhu, Imran G. House, Lev M. Kats, Andrew M. Scott, Benjamin Solomon, Simon J. Harrison, Jane Oliaro, Ian A. Parish, Kylie M. Quinn, Paul J. Neeson, Clare Y. Slaney, Junyun Lai, Paul A. Beavis, Phillip K. Darcy - Nature 2024 被引用: 214

  5. Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer

    著者: Balaji Virassamy, Franco Caramia, Peter Savas, Sneha Sant, Jianan Wang, Susan N. Christo, Ann Byrne, Kylie Clarke, Emmaline Brown, Zhi L. Teo, Bianca von Scheidt, David Freestone, Luke C. Gandolfo, Karsten E. Weber, Julia Teply‐Szymanski, Ran Li, Stephen J. Luen, Carsten Denkert, Sibylle Loibl, Olivia Lucas, Charles Swanton, Terence P. Speed, Phillip K. Darcy, Paul J. Neeson, Laura K. Mackay, Sherene Loi - Cancer Cell 2023 被引用: 221

  6. Clinical relevance of host immunity in breast cancer: from TILs to the clinic

    著者: Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K. Darcy, Mark J. Smyth, Sherene Loi - Nature Reviews Clinical Oncology 2015 被引用: 904

  7. Tumor immune evasion arises through loss of TNF sensitivity

    著者: Conor J. Kearney, Stephin J. Vervoort, Simon J. Hogg, Kelly M. Ramsbottom, Andrew J. Freeman, Najoua Lalaoui, Lizzy Pijpers, Jessica Michie, Kristin Brown, Deborah A. Knight, Vivien R. Sutton, Paul A. Beavis, Ilia Voskoboinik, Phillip K. Darcy, John Silke, Joseph A. Trapani, Ricky W. Johnstone, Jane Oliaro - Science Immunology 2018 被引用: 393

  8. Cellular networks controlling T cell persistence in adoptive cell therapy

    著者: Jack D. Chan, Junyun Lai, Clare Y. Slaney, Axel Kallies, Paul A. Beavis, Phillip K. Darcy - Nature reviews. Immunology 2021 被引用: 235

  9. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

    著者: Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, Junyun Lai, Amanda X. Y. Chen, Déborah Meyran, Kirsten L. Todd, Emma V. Petley, Sherly Mardiana, Christina Mølck, Gregory D. Stewart, Benjamin Solomon, Ian A. Parish, Paul J. Neeson, Simon J. Harrison, Lev M. Kats, Imran G. House, Phillip K. Darcy, Paul A. Beavis - Nature Communications 2021 被引用: 210

  10. Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

    著者: Alexander J. Davenport, Ryan Cross, Katherine A. Watson, Yi‐Han Liao, W. Shi, H. Miles Prince, Paul A. Beavis, Joseph A. Trapani, Michael H. Kershaw, David Ritchie, Phillip K. Darcy, Paul J. Neeson, Misty R. Jenkins - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 被引用: 357

  11. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity

    著者: Junyun Lai, Sherly Mardiana, Imran G. House, Kevin Sek, Melissa A. Henderson, Lauren Giuffrida, Amanda X. Y. Chen, Kirsten L. Todd, Emma V. Petley, Jack D. Chan, Emma M. Carrington, Andrew M. Lew, Benjamin Solomon, Joseph A. Trapani, Katherine Kedzierska, Maximilien Evrard, Stephin J. Vervoort, Jason Waithman, Phillip K. Darcy, Paul A. Beavis - Nature Immunology 2020 被引用: 215

  12. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies

    著者: Ibraheem Nasir, Conor McGuinness, Ashleigh R. Poh, Matthias Ernst, Phillip K. Darcy, Kara L. Britt - Trends in Immunology 2023 被引用: 138

  13. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape

    著者: Leisha A. Emens, Paolo A. Ascierto, Phillip K. Darcy, Sandra Demaria, Alexander M.M. Eggermont, William L. Redmond, Barbara Seliger, Francesco M. Marincola - European Journal of Cancer 2017 被引用: 562

  14. PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity

    著者: Florian Wiede, Kun‐Hui Lu, Xin Du, Mara N. Zeissig, Rachel Xu, Pei Kee Goh, Chrysovalantou E. Xirouchaki, Samuel J. Hogarth, Spencer Greatorex, Kevin Sek, Roger J. Daly, Paul A. Beavis, Phillip K. Darcy, Nicholas K. Tonks, Tony Tiganis - Cancer Discovery 2021 被引用: 137

  15. Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

    著者: Liza B. John, Christel Devaud, Connie P.M. Duong, Carmen S. Yong, Paul A. Beavis, Nicole M. Haynes, Melvyn T. Chow, Mark J. Smyth, Michael H. Kershaw, Phillip K. Darcy - Clinical Cancer Research 2013 被引用: 700

  16. RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

    著者: Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Roberto Salgado, Carsten Denkert, Peter Savas, S.E. Combs, David L. Rimm, Jennifer M. Giltnane, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Rebecca S. Cook, Mark A. Pilkinton, S. Mallal, Kai Wang, Vincent A. Miller, Phil Stephens, Roman Yelensky, Franco D. Doimi, Henry Gómez, Sergey Ryzhov, Phillip K. Darcy, Carlos L. Arteaga, Justin M. Balko - Clinical Cancer Research 2015 被引用: 552

  17. BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

    著者: Simon J. Hogg, Stephin J. Vervoort, Sumit Deswal, Christopher J. Ott, Jason Li, Leonie A. Cluse, Paul A. Beavis, Phillip K. Darcy, Benjamin Martin, Andrew Spencer, Anna K. Traunbauer, Irina Sadovnik, Karin Bauer, Peter Valent, James E. Bradner, Johannes Zuber, Jake Shortt, Ricky W. Johnstone - Cell Reports 2017 被引用: 300

  18. T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models

    著者: Déborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean Macdonald, Thu Ngoc Nguyen, Minyu Wang, Niko Thio, Criselle D’Souza, Vicky Mengfei Qin, Clare Y. Slaney, Aaron J Harrison, Kevin Sek, Pasquale Petrone, Kevin Thia, Lauren Giuffrida, Andrew M. Scott, Rachael Terry, Ben Tran, Jayesh Desai, H. Miles Prince, Simon J. Harrison, Paul A. Beavis, Michael H. Kershaw, Benjamin Solomon, Paul G. Ekert, Joseph A. Trapani, Phillip K. Darcy, Paul J. Neeson - Science Translational Medicine 2023 被引用: 97

  19. Trafficking of T Cells into Tumors

    著者: Clare Y. Slaney, Michael H. Kershaw, Phillip K. Darcy - Cancer Research 2014 被引用: 406

  20. IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors

    著者: Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, Imran G. House, Junyun Lai, Amanda X. Y. Chen, Kirsten L. Todd, Emma V. Petley, Sherly Mardiana, Izabela Todorovski, Emily Gruber, Madison J. Kelly, Benjamin Solomon, Stephin J. Vervoort, Ricky W. Johnstone, Ian A. Parish, Paul J. Neeson, Lev M. Kats, Phillip K. Darcy, Paul A. Beavis - Molecular Therapy 2020 被引用: 107

  21. Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

    著者: David S. Ritchie, Paul J. Neeson, Amit Khot, Stefan Peinert, Tsin Yee Tai, Kellie M. Tainton, Karen Chen, Mandy Shin, Dominic Wall, Dirk Hönemann, Peter Gambell, David Westerman, Javier Haurat, Jennifer A. Westwood, Andrew M. Scott, L. Ya. Kravets, Michael Dickinson, Joseph A. Trapani, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw, H. Miles Prince - Molecular Therapy 2013 被引用: 433

  22. Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

    著者: Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida, Jane K. Mills, Kevin Sek, Ryan Cross, Alexander J. Davenport, Liza B. John, Sherly Mardiana, Clare Y. Slaney, Ricky W. Johnstone, Joseph A. Trapani, John Stagg, Sherene Loi, Lev M. Kats, David Gyorki, Michael H. Kershaw, Phillip K. Darcy - Journal of Clinical Investigation 2017 被引用: 321

  23. Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

    著者: Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson, Liza B. John, Bertrand Allard, Sherene Loi, Michael H. Kershaw, John Stagg, Phillip K. Darcy - Cancer Immunology Research 2015 被引用: 329

  24. Activating and inhibitory receptors of natural killer cells

    著者: Hollie J. Pegram, Daniel M. Andrews, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw - Immunology and Cell Biology 2010 被引用: 544